Actionable insights straight to your inbox

logo_equities.svg

Windtree Shows New Positive Phase 2b Data in Respiratory Distress Syndrome Infants

Data shows reduced incidence and severity of bronchopulmonary dysplasia in preterm Infants with RDS (Image: Windtree Therapeutics)